Nycomed Pharma AS - Norway Miza Ireland Limited - Ireland Abbott S.p.A. - Italy
| Държава: | Италия |
| Кратка информация: | Nycomed is a privately owned, global mid-sized pharmaceutical company with headquarters in Zurich, Switzerland. The company employs 12,500 associates worldwide and has affiliates in more than 70 countries, bringing medicines that matter to patients worldwide. Nycomed has a strong presence in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best-in-class partners. The company has built a flexible business model around partnering to grow its R&D pipeline, its product portfolio, and extend its geographical reach. Business results and main therapeutic areas In 2010, total net turnover reached €3.2 billion, with an adjusted EBITDA of €851 million. Nycomed ranks 28th among global pharmaceutical companies. Nycomed offers a diversified product range focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Global R&D and Manufacturing presence Research and Development is conducted at three sites in Europe and one in India. New products are sourced from our own internal Discovery organisation and in-licensed from external companies such as small biotechs. Establishing long-term partnerships is a cornerstone of Nycomed´s growth strategy. Nycomed has 15 manufacturing sites: 5 centres of competence in Europe for global products as well as 10 production sites for regional products in fast-growing countries such as Brazil and Mexico. A major investment is being made in a new pharmaceutical plant in Russia, currently Nycomed’s biggest single market. |
| Сайт: | http://www.nycomed.com/ |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
